Association of ADRA2A and MTHFR gene polymorphisms with weight loss following antipsychotic switching to aripiprazole or ziprasidone
ObjectivesVarious genetic polymorphisms have been reported to be associated with antipsychotic-induced weight gain. In this study, we aimed to determine whether risk polymorphisms in 12 candidate genes are associated with reduction in body mass index (BMI) of patients following switching of antipsyc...
Prif Awduron: | Roffeei, S.N., Reynolds, G.P., Zainal, N.Z., Said, M.A., Hatim, A., Aida, S.A., Mohamed, Z. |
---|---|
Fformat: | Erthygl |
Cyhoeddwyd: |
2014
|
Pynciau: |
Eitemau Tebyg
-
Association of FTO, LEPR and MTHFR gene polymorphisms with metabolic syndrome in schizophrenia patients receiving antipsychotics
gan: Roffeei, S.N., et al.
Cyhoeddwyd: (2014) -
An open-label study of aripiprazole for methamphetamine induced psychosis
gan: Sulaiman, A.H., et al.
Cyhoeddwyd: (2012) -
A randomized, placebo-controlled trial of aripiprazole for the treatment of methamphetamine dependence and associated psychosis
gan: Sulaiman, A.H., et al.
Cyhoeddwyd: (2013) -
Association of a functional FAAH polymorphism with methamphetamine-induced symptoms and dependence in a Malaysian population
gan: Sim, M.S., et al.
Cyhoeddwyd: (2013) -
Service utilization and osts associated with switching to risperidone from previous treatment with typical antipsychotic agents
gan: Sulaiman, Ahmad Hatim, et al.
Cyhoeddwyd: (2010)